HCW Biologics Inc
Research HCW Biologics Inc (HCWB) on Bullrun: market cap USD 2.92M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHCWB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.92M
- Financial periodQ1 2026
- RevenueUSD 6.54M
- Net incomeUSD 3.47M
- Free cash flow-USD 11.45M
- Gross margin99.8%
Valuation Snapshot
latest market cap is USD 2.92M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 54.23K | -USD 7.96M | -USD 13.39M | 20.0% | -10.63 | USD 1.95M | USD 6.81M | USD 2.76M |
| FY2024 | USD 2.57M | -USD 30.02M | -USD 14.49M | 37.4% | -30.96 | USD 4.67M | USD 13.69M | -USD 6.77M |
| FY2023 | USD 2.84M | -USD 24.99M | -USD 28.72M | 19.7% | -0.7 | USD 3.60M | USD 6.42M | USD 13.46M |
| FY2022 | USD 6.72M | -USD 14.90M | -USD 20.66M | 38.5% | -0.42 | USD 22.33M | USD 44.68M | USD 37.43M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.92M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.62M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 19.86M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 44.07M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 68.69M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 82.98M | n/a | n/a | n/a |
About HCW Biologics Inc
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HCW Biologics Inc's market cap?
HCW Biologics Inc's market capitalization is USD 2.92M.
What does HCW Biologics Inc do?
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases.